The clinical effects of peramivir on influenza virus infections in infants (age; over 28 days old, under 4 years old): an open-label,non-randomized, multi-centre study.
Not Applicable
- Conditions
- Infants with Influenza virus infections.
- Registration Number
- JPRN-UMIN000007328
- Lead Sponsor
- Takasaki Pediatric Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Not provided
Exclusion Criteria
History of hypersensitivity caused by neuraminidase inhibitors. Patients who are deemed to be inappropriate by the investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to return to normal body temperature (under 37.5 degrees).
- Secondary Outcome Measures
Name Time Method Ratio of influenza virus-positive patients. Virus mutation after treatment of peramivir. Duration of influenza symptoms.